Quick answers
- What is Adcirca?
- Adcirca is a brand name of Tadalafil, a prescription medicine. The FDA NDC Directory lists 1 Adcirca product in 1 strength and form.
- Who makes Adcirca?
- Eli Lilly Co holds the FDA application for Adcirca (NDA022332, approved May 22, 2009).
- Is there a generic or store brand of Adcirca?
- Yes. The FDA NDC Directory lists 30 other products with the same active ingredients, strength and form as a Adcirca product, 30 of them generic. Ask your pharmacist whether one is right for you.
- Has Adcirca been recalled?
- No recall linked to Adcirca products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Adcirca is
Each Adcirca product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Tadalafil · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| tadalafil 20 mg tablet (oral) | Adcirca | 30 products, 18 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Tadalafil →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA022332 | Eli Lilly Co | May 22, 2009 | 1 |
Companies that list Adcirca
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Adcirca products.
- United Therapeutics Corporation1 product
Recalls
No recall linked to Adcirca products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.